Category Archives: Business and Investments

Latest From Business and Investments

What BIO2012 Meant to Boston and the Netherlands

The 2012 BIO International Convention will be held June 18-21, 2012 at the Boston Convention and Exhibition Center in Boston, MA

We came across this recent post in Boston.com about the BIO International Convention and BIO Business Forum. It’s not just a recap of the event, but it’s a specific piece on one company’s goals, connecting Boston with the Netherlands. As you know, the BIO One-on-One Partnering System is open and accessible to attendees well after the conference shuts down and everyone goes home. This allows you to do your follow-up: go through your Inbox, research Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , ,

Indices, IPOs, Approvals – YTD Update Aug 14th, 2012

We are now more than eight months into the year and biotech indices have maintained their outperformance, squeezed out a modest size IPO class, and delivered double digit novel FDA approvals. 1. Indices. The Nasdaq Biotech Index (NBI) is up 27% Year to Date (YTD) as of last Friday. It was up nearly 20% by the end of the 1st quarter, consolidated during the 2nd quarter, and has participated in the summer rally to tack on another 7%. Here Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Recommended Reading from BIOtechNOW

Partnering Meetings

We hope the dust has settled from Boston’s International Convention, and you’re ready for a busy fall schedule! Here’s just a quick post on some recent articles that have been published on BIOtechNOW that’s worth a read. 2012 Fall Event Preview – A recap of BIO’s upcoming BD events, among others. 2012 BIO Convention in China: Highlighting Cross-Border Partnering in Biotechnology – Take a deeper look at the 2nd Annual BIO China event. We’re also Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Indices, IPOs, and New Drug Approvals – Update July 6th 2012

Index-Perfomance-June-2012-thumb

1. Stock Performance. The Nasdaq Biotech Index (NBI) continued on its path of outperforming the market, up 24.6 percent and increasing its Year-to-Date (YTD) lead over the S&P 500 which is up 8.3 percent. The Amex Biotech Index (BTK) closed out June up a hefty 34.6 percent YTD: 2. IPOs: Tesaro, Inc. (TSRO) was June’s sole U.S. IPO, raising $81M.  The company was formed just two years ago and has aggressively in-licensed cancer treatments from Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

#Partnering Wrap Up for BIO International Convention

forum-bio

A very big thank you to all the companies, sponsors, and attendees of the BIO Business Forum and Exhibitor Partnering. We’re very excited at the level of activity, feedback, and business getting done, right in the biotech hub of Boston. As you know, we scheduled over 25,000 meetings. Here are the official stats, as of this morning: Total Requests    127,635 Scheduled Meetings    25,291 Companies    2,900 Countries    58 What do those stats really mean? Here’s the Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , , ,